The contractor shall provide preclinical development support for candidate products and drug development activities. The scope of work encompasses activities that range from initial product…

Active Awarded Last action

Contract number
75N93021D00002
Awardee
Awarding agency
Task orders
2 $17,148 obligated

Award facts

Opportunity
Combined order value
$17,148 Current and potential, with all options
Last date to order 86% complete
IDV ceiling <1% used
$107,274,471.00
Maximum order
$107,274,471.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services, has awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract worth up to $107,274,471 to provide preclinical development support for candidate products and drug development activities related to HIV, hepatitis B and C, and tuberculosis. This multiple-award IDIQ contract has a 7-year period of performance from October 2020 to October 2027. The scope of work encompasses a wide range of preclinical services across seven task areas, including in vitro testing, synthesis of therapeutic agents, small animal models, formulation development, pharmacology and toxicology, and a reagent program. One of the prime contractors is Alchem Laboratories Corporation, a for-profit manufacturer registered in Florida. Alchem has been awarded task orders totaling over $17 million under this IDIQ to provide quality assurance planning, reagent programs, and therapeutic agent synthesis in support of the NIAID's HIV/AIDS research.

Description

As the agency reported it.

The contractor shall provide preclinical development support for candidate products and drug development activities. The scope of work encompasses activities that range from initial product discovery to those required to support clinical trials and/o

Task orders

Task order Ordering agency Obligated Awarded
The purpose of this task order is the development and delivery of a quality assurance/quality control (QA/QC) plan… 75N93021F00002 National Institute of Allergy and Infectious Diseases (NIH) $17,148
The purpose of this task order is to fund the guaranteed minimum amount of the contract. 75N93021F00001 National Institute of Allergy and Infectious Diseases (NIH) $0

Transactions

Action Obligated Date
Other Administrative Action P00004 $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $0

Quick answers

Who was awarded contract 75N93021D00002?

75N93021D00002 was awarded to Alchem Laboratories Corporation by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on October 15, 2020.

How much is contract 75N93021D00002 worth?

Orders under 75N93021D00002 have obligated $17,148. 75N93021D00002's own ceiling is $107,274,471. A single order can be worth up to $107,274,471.

How many orders have been placed under contract 75N93021D00002?

2 orders have been placed under 75N93021D00002, the latest on April 15, 2021.

Who can order from contract 75N93021D00002?

75N93021D00002 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract 75N93021D00002 part of a contract vehicle?

Yes. 75N93021D00002 is part of Preclinical Services for HIV Therapeutics.

Was contract 75N93021D00002 competed?

The extent of competition for 75N93021D00002 was full and open competition. The government received 3 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login